#Sustainability #None #Zentiva #pharmaceuticals

Zentiva's 2025 Sustainability Report: A Commitment to a Healthier Future

On March 16, 2026, Zentiva proudly unveiled its 2025 Sustainability Report, showcasing another year of meaningful advancements in public health initiatives, environmental stewardship, and responsible business practices. As a leading European manufacturer of generic medications, Zentiva is setting an example of how business growth can be harmonized with sustainability.

Key Achievements of 2025

In a year marked by challenges due to global health crises, Zentiva achieved impressive milestones:

• - Emission Reductions: The company successfully reduced its Scope 1 and 2 emissions by 10%, all while boosting its net sales and EBITDA.
• - Renewable Energy Usage: An impressive 83% of the electricity consumed in Zentiva's operations now comes from renewable sources, with 100% in its EU manufacturing plants.
• - Water Conservation: The volume of recycled and reused water nearly doubled between 2021 and 2025, underlining the company’s commitment to efficient water resource management.
• - Waste Management: Approximately 47% of waste is now diverted from landfills through reuse and recycling initiatives.
• - Reforestation Initiatives: Over 130,000 trees have been planted, and 3.5 million bees were adopted to promote biodiversity through Zentiva's biodiversity initiatives.
• - Community Projects: In 2025, Zentiva undertook over 120 projects aimed at supporting individuals and communities across Europe and India under the hashtag #HelpingOthers.

These efforts earned Zentiva a gold medal from EcoVadis, placing it in the top 2% of the pharmaceutical industry's sustainability ratings. Additionally, the company received the 2025 Transparency Award from EUPD Group for its outstanding communication and reporting on sustainability efforts.

Leadership Statements

Steffen Saltofte, CEO of Zentiva, emphasized the company’s dual responsibility: “As one of Europe’s leading generic medicine manufacturers, we are committed to supporting public health systems while minimizing our environmental footprint. Millions of people rely on the affordability and accessibility of the medicines we produce and distribute every day.”

Ines Windisch, Director of Corporate Affairs and Sustainability, added, “The Sustainability Report illustrates how our daily actions contribute to healthier communities and a healthier planet. Protecting people and the environment go hand in hand, and fostering sustainability is a continuous commitment we embrace every day, in every aspect of our work.”

Importance in the Pharmaceutical Industry

Zentiva plays a crucial role in ensuring that individuals across Europe can access high-quality and affordable medications. Generics account for roughly 70% of all dispensed medications, yet only 19% of pharmaceutical expenditure, making them vital for the affordability and sustainability of public health systems (IQVIA, 2024).

As integral to the health landscape as ever, Zentiva is not resting on its laurels. The company continues to invest in its manufacturing infrastructure and sustainability strategy to ensure that patients will have consistent access to essential medications now and in the future.

To delve deeper into the comprehensive sustainability efforts and achievements, the full 2025 Sustainability Report can be found at www.zentiva.com/sustainability.

About Zentiva

Zentiva is dedicated to providing health and wellness for generations, focusing on developing, producing, and distributing high-quality, affordable medications to more than 100 million people across 40 countries in Europe. With four manufacturing plants and a robust network of external manufacturing partners, Zentiva ensures a reliable supply of its products. The company employs over 5,400 professionals across 30 countries, united in their commitment to the individuals who depend on their medications every day. For more information, visit www.zentiva.com.